Verdence Capital Advisors’s Boston Scientific BSX Stock Holding History

Verdence Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Sell	6,694 -519	-7%	-$28.2K	0.02%	558
2026 Q1	$453K	Sell	7,213 -5,052	-41%	-$404K	0.03%	447
2025 Q4	$1.17M	Sell	12,265 -4,313	-26%	-$423K	0.07%	252
2025 Q3	$1.7M	Buy	16,578 +13,167	+386%	+$1.36M	0.1%	209
2025 Q2	$366K	Sell	3,411 -391	-10%	-$39.6K	0.03%	502
2025 Q1	$384K	Sell	3,802 -67	-2%	-$6.75K	0.03%	468
2024 Q4	$346K	Sell	3,869 -138	-3%	-$12.1K	0.03%	464
2024 Q3	$336K	Buy	4,007 +165	+4%	+$13K	0.03%	488
2024 Q2	$296K	Buy	3,842 +75	+2%	+$5.49K	0.03%	472
2024 Q1	$258K	Sell	3,767 -99	-3%	-$6.37K	0.02%	524
2023 Q4	$223K	Buy	+3,866	New	+$206K	0.02%	524

Other funds holding BSX

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Verdence Capital Advisors's BSX Position: Q2 2026 in Review

Verdence Capital Advisors reduced its Boston Scientific (BSX) stake by 7.2% in Q2 2026, selling an estimated $28.2K and leaving 6,694 shares worth $286K. The position accounts for 0.02% of the portfolio, ranked #558.

Verdence Capital Advisors first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.7M in Q3 2025. 569 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Verdence Capital Advisors held 6,694 shares of Boston Scientific worth $286K as of Q2 2026.
Verdence Capital Advisors sold 519 Boston Scientific shares in Q2 2026, an estimated $28.2K.
Boston Scientific made up 0.02% of Verdence Capital Advisors's portfolio in Q2 2026, its #558 holding.
Verdence Capital Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Verdence Capital Advisors's Boston Scientific position peaked at $1.7M in Q3 2025.
569 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.